[Pediatric bone marrow alterations]

Sebastian Berg1

  • 1Kinderradiologie, Universitätsklinik Freiburg, Mathildenstraße 1, 79106, Freiburg, Deutschland. sebastian.berg@uniklinik-freiburg.de.

Der Radiologe
|January 5, 2021
PubMed

Insights

Bone marrow development follows a predictable pattern impacting disease localization. Magnetic resonance imaging (MRI) aids in differentiating benign bone marrow changes from malignant infiltrations based on age-specific patterns.

Area of Science:

  • Radiology
  • Hematology
  • Medical Imaging

Background:

  • Bone marrow development exhibits a consistent, age-dependent pattern.
  • This pattern influences the location and appearance of bone marrow abnormalities.
  • Distinguishing physiological/benign changes from inflammatory/malignant conditions is crucial.

Purpose of the Study:

  • To highlight the importance of age-dependent bone marrow patterns in diagnostics.
  • To emphasize the role of magnetic resonance imaging (MRI) in bone marrow evaluation.
  • To differentiate benign bone marrow alterations from infiltrative processes.

Main Methods:

  • Review of age-specific bone marrow morphology on MRI.
  • Correlation of imaging findings with known patterns of bone marrow processes.
  • Emphasis on MRI as the primary modality for bone marrow assessment.

Main Results:

  • Bone marrow exhibits characteristic age-related changes in its composition and appearance.
  • Specific MRI features and age distributions aid in classifying bone marrow findings.
  • MRI effectively differentiates physiological, reactive, and benign alterations from inflammatory or malignant infiltrations.

Conclusions:

  • Age-dependent bone marrow patterns are key diagnostic indicators.
  • Magnetic resonance imaging is the optimal modality for assessing bone marrow composition.
  • MRI findings, combined with age, facilitate accurate differentiation of bone marrow pathologies.

Related Concept Videos

Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
642
Overview of Hematopoiesis01:20

Overview of Hematopoiesis

Hematopoiesis, or blood cell production, is a vital biological process that begins early in embryonic development and continues throughout life. This process generates the various types of cells found in blood, including red blood cells, white blood cells, and platelets from hematopoietic stem cells (HSCs).
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
6.8K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
89
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
132
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
109
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
107